Gene · 5920
Papers2,936
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,936
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome analysis of skeletal muscle in dermatomyositis, polymyositis, and dysferlinopathy, using a bioinformatics approach. | Front Neurol | 2023 | 38125829 | PubTator, text mining | PubMed |
| Gene expression profile of HCT-8 cells following single or co-infections with Cryptosporidium parvum and bovine coronavirus. | Sci Rep | 2023 | 38092824 | PubTator, text mining | PubMed |
| The role of IBV PL1pro in virus replication and suppression of host innate immune responses. | BMC Vet Res | 2023 | 38087313 | PubTator, text mining | PubMed |
| Shedding light on the molecular and regulatory mechanisms of TLR4 signaling in endothelial cells under physiological and inflamed conditions. | Front Immunol | 2023 | 38077393 | PubTator, text mining | PubMed |
| PANoptosis in cancer, the triangle of cell death. | Cancer Med | 2023 | 38069556 | PubTator, text mining | PubMed |
| NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases-A Lesson from Cytokine Storm Syndrome. | Int J Mol Sci | 2023 | 38068879 | PubTator, text mining | PubMed |
| Antiviral Effects of Secondary Metabolites from Jatropha podagrica Leaves against the Pseudotyped Virus of SARS-CoV-2 Omicron. | Plants (Basel) | 2023 | 38068579 | PubTator, text mining | PubMed |
| Advances of Protein Palmitoylation in Tumor Cell Deaths. | Cancers (Basel) | 2023 | 38067206 | PubTator, text mining | PubMed |
| The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment. | Exp Hematol Oncol | 2023 | 38066523 | PubTator, text mining | PubMed |
| IL-17RA promotes pathologic epithelial inflammation in a mouse model of upper respiratory influenza infection. | PLoS Pathog | 2023 | 38060620 | PubTator, text mining | PubMed |
| Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance, and therapeutic targets. | Signal Transduct Target Ther | 2023 | 38057315 | PubTator, text mining | PubMed |
| Novel immunotherapeutic options for BCG-unresponsive high-risk non-muscle-invasive bladder cancer. | Cancer Med | 2023 | 38037752 | PubTator, text mining | PubMed |
| The role of post-transcriptional regulation in SARS-CoV-2 infection and pathogenicity. | Front Immunol | 2023 | 38035086 | PubTator, text mining | PubMed |
| Chicken IFI6 inhibits avian reovirus replication and affects related innate immune signaling pathways. | Front Microbiol | 2023 | 38033564 | PubTator, text mining | PubMed |
| Porcine promyelocytic leukemia protein isoforms suppress Japanese encephalitis virus replication in PK15 cells. | Virol J | 2023 | 38031162 | PubTator, text mining | PubMed |
| Disturbance of Adaptive Immunity System Was Accompanied by a Decrease in Plasma Short-Chain Fatty Acid for Patients Hospitalized During SARS-CoV-2 Infection After COVID-19 Vaccination. | J Inflamm Res | 2023 | 38026252 | PubTator, text mining | PubMed |
| EBV-Encoded MicroRNA-BART17-3p Targets DDX3X and Promotes EBV Infection in EBV-Associated T/Natural Killer-Cell Lymphoproliferative Diseases. | Open Forum Infect Dis | 2023 | 38023563 | PubTator, text mining | PubMed |
| Viral Subversion of the Chromosome Region Maintenance 1 Export Pathway and Its Consequences for the Cell Host. | Viruses | 2023 | 38005895 | PubTator, text mining | PubMed |
| Suppression of Innate Immunity by the Hepatitis C Virus (HCV): Revisiting the Specificity of Host-Virus Interactive Pathways. | Int J Mol Sci | 2023 | 38003289 | PubTator, text mining | PubMed |
| The Renin-Angiotensin System: The Challenge behind Autoimmune Dermatological Diseases. | Diagnostics (Basel) | 2023 | 37998534 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5920/papers?page=5